Slimming
Although many of the "slimming" peptides developed have been around for many years, relatively recent approvals have caused an explosion in their popularity. The majority of them are GLP-1 variations and have been primarily developed (and approved where applicable) for treatment of type 2 diabetes.
- GLP-1
- Semaglutide / Ozempic / Wegovy / Rybelsus
- Dulaglutide / Trulicity
- Liraglutide / Victoza / Saxenda
- Exenatide / Byetta / Bydureon
- Tirzepatide / Mounjaro
- Cagrilintide / CagriSema
- Retatrutide
- Lixisenatide
- Albiglutide
- Mazdutide
 |
 |
 |
 |
 |
 |